Consortium Catalogs Complex Structural Variation in Human Genomes With Hybrid Long-Read Assembly
Premium
The Human Genome Structural Variation Consortium recently released a new variant database generated from 65 nearly complete human genomes with T2T status.
CMS Final Pricing for Genomic Procedure Codes Leaves Lab, Industry Stakeholders Wanting More
Premium
After going through the gapfill process and releasing final pricing for six codes related to genomic sequencing procedures, the final pricing still has stakeholders worried.
Association for Molecular Pathology 'In Limbo' as FDA Lawsuit Moves Ahead, LDT Regulations Loom
Premium
At the AMP annual meeting this week, leadership briefed members on what to expect as its lawsuit challenging the FDA final rule on laboratory-developed test regulation unfolds.
Jury Awards Guardant Health $292.5M in False Advertising Lawsuit Against Natera
The companies have both claimed that the other has engaged in false advertising related to Signatera and Reveal MRD assays.
Oxford Nanopore Technologies, UK Biobank Partner to Build Large-Scale Epigenetic Database
The initiative plans to profile the epigenomes of 50,000 UK Biobank participants, most of them healthy individuals, using nanopore sequencing.
International Pathogen Surveillance Network Awards $2M in First Round of Grants
The network awarded funding to 10 projects aimed at increasing genomic surveillance capacity in low- and middle-income countries.
Natera Prospera Lung Test Receives Medicare Coverage for Single Lung Transplant Patients
The test was launched in 2022 and received coverage for double-lung transplant patients in 2023.